Tag: 280e

An industry-wide end to 280E would do more than lower tax bills. A Schedule III shift could reshape cash flow, capital planning, debt management, and operational investment for cannabis businesses. Finance leaders who model scenarios now and decide how they would deploy released cash may be better positioned to strengthen their companies before competition and capital demands intensify.

While the federal reclassification of cannabis to Schedule III is being hailed as a historic milestone, for dispensary owners, the “victory” comes with a complex set of operational strings attached. From the selective application of 280E tax relief to the slow-moving evolution of the banking sector, the transition is more about precision than celebration. This guide breaks down why the “medical lane” is the new front line of profitability, how to audit your revenue streams for upcoming tax shifts, and why compliance documentation is now more critical than ever.

The Department of Justice moving cannabis from Schedule I to Schedule III is a historic shift, but it isn’t a universal fix. From the multi-million-dollar 280E tax opportunity to the ongoing hurdles for adult-use operators, we break down the real business impact of the 2026 rescheduling order and why federal oversight is about to get a lot more complex.

The DEA isn’t stepping back; it’s stepping in. While the industry celebrates the end of 280E, the fine print of the new Schedule III order reveals a mandatory federal middleman, undisclosed fees, and a legal “prescription” trap that could leave dispensaries in limbo. Here is what the rescheduling order actually means for your bottom line.

PORTLAND, Ore. – Analysts at Whitney Economics (WE) estimates cannabis businesses paid $2.24 billion in excess cannabis-related federal taxes in 2025 due to the...

A potential move of cannabis to Schedule III could eventually reshape the industry’s tax burden by ending the reach of Section 280E. But operators should not confuse political momentum with immediate relief. A CPA explains why retroactive tax refunds are unlikely and disciplined compliance still matters. From defensible cost accounting to scenario planning and entity-structure review, the smartest path is cautious preparation rather than reactive change.

Schedule III could reduce the tax drag that has warped cannabis operating models for years, but it won’t be a universal win. The real advantage will go to operators who treat post-280E relief as a catalyst: moving faster, tightening inventory and receivables, stress-testing pricing and production, and getting books “deal-ready” before M&A velocity spikes. In the gap between improved economics and slower-moving capital markets, preparedness becomes market power.

Employee Stock Ownership Plans (ESOPs) are changing the way cannabis companies think about equity. By turning workers into owners, ESOPs improve retention, create generational wealth, and align business growth with social justice goals.

WASHINGTON – Cannabis rescheduling is up in the air again after the administrative law judge assigned to hear arguments for and against the proposal...

Twenty-five years after Colorado legalized medical cannabis and a decade since greenlighting adult-use sales, the Centennial State made history again as one of the...